Navigation Links
Cepheid Extends Rapid Molecular Diagnostics' Leadership with FDA Clearance of Xpert Clostridium difficile/Epi
Date:4/11/2011

vid Persing, M.D., Ph.D., Cepheid's Chief Medical and Technology Officer. "The use of Cepheid's special nucleic acid chemistry capability was critical to achieving the required performance levels of this sophisticated next-generation test, which targets two toxin genes and a regulatory point mutation."

The Xpert C. difficile/Epi test, which runs on the GeneXpert® system, is Cepheid's tenth Xpert test to receive FDA clearance. It is expected to be available for shipment the week of May 16.

About CepheidBased in Sunnyvale, Calif., Cepheid (Nasdaq: CPHD) is a leading molecular diagnostics company that is dedicated to improving healthcare by developing, manufacturing, and marketing accurate yet easy-to-use molecular systems and tests. By automating highly complex and time-consuming manual procedures, the company's solutions deliver a better way for institutions of any size to perform sophisticated genetic testing for organisms and genetic-based diseases. Through its strong molecular biology capabilities, the company is focusing on those applications where accurate, rapid, and actionable test results are needed most, such as managing infectious diseases and cancer. For more information, visit http://www.cepheid.com.

This press release contains forward-looking statements that are not purely historical regarding Cepheid's or its management's intentions, beliefs, expectations and strategies for the future, including those relating to product performance, future products and future market opportunities. Because such statements deal with future events, they are subject to various risks and uncertainties, and actual results could differ materially from the company's current expectations. Factors that could cause actual results to differ materially include risks and uncertainties such as those relating to: unforeseen manufac
'/>"/>

SOURCE Cepheid
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cepheid Announces Termination of Contract With the Centers for Disease Control and Prevention to Develop Rapid Point of Care Test for Avian Influenza
2. Cepheid Launches New GeneXpert(R) Tests in Europe for Simultaneous, Rapid Detection of Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus
3. Cepheid GeneXpert(R) System and Xpert(TM) MRSA Selected for up to 11 Victoria, Australia Hospitals in Rollout of Start Clean Strategy
4. Cepheid Announces CE IVD Release of First On-Demand Test for van A/van B Genes Most Associated With Hospital-Acquired VRE Infection
5. Cepheid Molecular Diagnostic Test for Positive Blood Culture Bottles Categorized Moderate Complexity by FDA
6. Cepheid Announces European Release of First On-Demand Molecular Test for Simultaneous Detection of Mycobacterium tuberculosis (TB) and Resistance to Rifampicin
7. Cepheid Receives Grant to Develop Ten-Color Real-Time PCR Detection Technology for Use in the GeneXpert(R) System
8. Cepheid Reports 2009 Third Quarter Results
9. Cepheid to Webcast Upcoming Financial Presentations
10. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia
11. Cepheid to Webcast Upcoming Financial Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)...  The World MS Day campaign led by the ... awareness of multiple sclerosis and those living with MS ... will move us closer a world free of MS. ... including the National MS Society, have events and planned ... MS Day campaign theme is "access." Whether it is ...
(Date:5/27/2015)...  A special presentation at Digestive Disease Week ... successful experience using  Stretta Therapy  to ... Ronnie Fass , MD, of ... reviewed clinical data on Stretta. Expert panelists then ... Stretta has helped them treat.      Dana ...
(Date:5/27/2015)... Nev. , May 27, 2015  PDL BioPharma, ... John P. McLaughlin , the company,s president and ... Global Healthcare Conference next week in New York City.  ... Wednesday, June 3, 2015 at 11:30 a.m. EDT. ... of the presentation, go to the Company,s website at ...
Breaking Medicine Technology:People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 2People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 3People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 4People Around The World Are Sharing What Makes Them Stronger Than Multiple Sclerosis 5DDW Presentation Examines Stretta As A Versatile And Effective GERD Treatment For Multiple Patient Populations 2DDW Presentation Examines Stretta As A Versatile And Effective GERD Treatment For Multiple Patient Populations 3PDL BioPharma to Present at Jefferies 2015 Global Healthcare Conference 2
... Agendia, a commercial-stage molecular cancer diagnostics ... Breast Cancer Conference (2011) Expert Panel,s recommendations highlight the ... particular biological subtype of their tumor - in guiding ... panel, "it is no longer tenable to consider breast ...
... -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner ... disposables and non-woven fabric made from 100% natural PurCotton® products in ... June 30, 2011. Fiscal Third ... (in millions of USD, except per share data)Q3 , FY2011 ...
Cached Medicine Technology:International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 2International St. Gallen Expert Panel Highlights Importance of Molecular Subtyping in Breast Cancer Treatment 3Winner Medical Reports Third Quarter Fiscal 2011 Results 2Winner Medical Reports Third Quarter Fiscal 2011 Results 3Winner Medical Reports Third Quarter Fiscal 2011 Results 4Winner Medical Reports Third Quarter Fiscal 2011 Results 5Winner Medical Reports Third Quarter Fiscal 2011 Results 6Winner Medical Reports Third Quarter Fiscal 2011 Results 7Winner Medical Reports Third Quarter Fiscal 2011 Results 8Winner Medical Reports Third Quarter Fiscal 2011 Results 9Winner Medical Reports Third Quarter Fiscal 2011 Results 10Winner Medical Reports Third Quarter Fiscal 2011 Results 11Winner Medical Reports Third Quarter Fiscal 2011 Results 12Winner Medical Reports Third Quarter Fiscal 2011 Results 13Winner Medical Reports Third Quarter Fiscal 2011 Results 14Winner Medical Reports Third Quarter Fiscal 2011 Results 15
(Date:5/27/2015)... CompanionDx announced that its ... analysis in personalized cancer therapy: Non-small cell lung cancer ... of Clinical Oncology (ASCO) as part of their annual ... The molecular and clinical data used for the study ... The study reports improved patient outcomes from a preliminary ...
(Date:5/27/2015)... On June 5, Plan B [the ... with LifeSource to host Donate Your Break, a public ... a LifeSource donor coach outside of 116 W. Illinois ... Demand for whole blood units is highest for LifeSource, ... months. LifeSource requires approximately 1,000 donations per day to ...
(Date:5/27/2015)... Texas (PRWEB) May 27, 2015 ... the current state of the Omega-3 industry. The ... including definitions, classifications, applications and industry chain structure. ... international markets including development trends, competitive landscape analysis, ... Gc Rieber Oils, Camanchaca Fishing Company, Seadragon Marine ...
(Date:5/27/2015)... 2015 SonarMD, LLC, recently ... a first-of-its kind, cloud-based algorithmic process for ... chronic gastrointestinal disease. , Developed by noted ... allows physicians to monitor their patients’ health ... of electronic health assessment surveys. Using nationally ...
(Date:5/27/2015)... MD (PRWEB) May 27, 2015 “Heroin has ... that’s where our overdoses are coming from,” says Harford County ... on May 8th. In the surging heroin related incidents ... pushing for prevention education to prevent heroin addiction and subsequent ... a possession charge. Drug Rehab Baltimore is a drug and ...
Breaking Medicine News(10 mins):Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Donate Your Break and Save Lives at the River North Blood Drive 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:SonarMD™, LLC, Launches Game-Changing, IBD Population Health Management Platform 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3
... THIN CHILDREN MAY HAVE POORER LUNG FUNCTION ,A ... through midlife may be influenced by several factors, including birth ... United Kingdom analyzed health data from 252 patients, all aged ... the patients at age 49 to 51. Results showed that ...
... A minimally invasive surgical approach developed by head ... of Medicine has been cleared by the U.S. Food ... (Intuitive Surgical, Inc., Sunnyvale, California) has been cleared for ... select malignant tumors in adults. Drs. Gregory S. ...
... Energy and Commerce as part of an investigation into preventable ... report recommending further restrictions regarding duty hours for resident physicians ... safety, according to an article published in the January issue ... (JACR). In 2003, the Accreditation Council for ...
... sexual arousal, whereas in men, the responses of the ... other, according to Assistant Professor Meredith Chivers, from Queen,s ... Seto, Martin Lalumire, Ellen Laan, and Teresa Grimbos. Their ... and physiological measures of sexual arousal in men and ...
... osteoarthritis (OA) accounts for more disability in the elderly than ... other health benefits, can increase stresses on the joints of ... issue of PM&R: The journal of injury, function and ... ankle joint motions of running barefoot versus running in modern ...
... researchers halted the growth of blood vessels that tumors ... in the Journal of Experimental Medicine ( ... its effects on neuronal growth, the team found that ... human blood vessels. By diminishing {delta}-catenin expression, the team ...
Cached Medicine News:Health News:News briefs from the January issue of Chest 2Health News:FDA clears TransOral robotic surgery developed at Penn 2Health News:FDA clears TransOral robotic surgery developed at Penn 3Health News:Institute of Medicine recommends stricter resident duty hour regulations to prevent medical errors 2Health News:Women's bodies and minds agree less than men's on what's sexy 2Health News:Running shoes may cause damage to knees, hips and ankles 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: